CBFA2T2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.982200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.833600E-01
Normal-vs-Stage2
4.054600E-01
Normal-vs-Stage3
7.531800E-02
Normal-vs-Stage4
2.795800E-01
Stage1-vs-Stage2
3.536800E-01
Stage1-vs-Stage3
1.071170E-01
Stage1-vs-Stage4
3.526600E-01
Stage2-vs-Stage3
2.740200E-01
Stage2-vs-Stage4
7.697200E-01
Stage3-vs-Stage4
3.133600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.330600E-01
Normal-vs-AfricanAmerican
7.284400E-01
Normal-vs-Asian
2.557200E-01
Caucasian-vs-AfricanAmerican
8.565000E-01
Caucasian-vs-Asian
5.490800E-01
AfricanAmerican-vs-Asian
4.733600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.425400E-01
Normal-vs-Female
3.283000E-01
Male-vs-Female
2.776400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.970600E-01
Normal-vs-Age(41-60Yrs)
6.374600E-01
Normal-vs-Age(61-80Yrs)
6.251400E-01
Normal-vs-Age(81-100Yrs)
3.883600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.961600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.274200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.818200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.083600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.256100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.717500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.881760E-01
Normal-vs-Daily Drinker
6.156600E-01
Normal-vs-Weekly Drinker
1.030380E-01
Normal-vs-Occasional Drinker
7.815000E-01
Normal-vs-Social Drinker
8.255600E-01
Non Drinker-vs-Daily Drinker
3.771200E-01
Non Drinker-vs-Weekly Drinker
8.755000E-01
Non Drinker-vs-Occasional Drinker
1.062380E-01
Non Drinker-vs-Social Drinker
1.229160E-01
Daily Drinker-vs-Weekly Drinker
4.368400E-01
Daily Drinker-vs-Occasional Drinker
6.203600E-01
Daily Drinker-vs-Social Drinker
2.921400E-01
Weekly Drinker-vs-Occasional Drinker
1.653610E-01
Weekly Drinker-vs-Social Drinker
1.366630E-01
Occasional Drinker-vs-Social Drinker
4.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.932800E-01
Normal-vs-Grade 2
1.777750E-01
Normal-vs-Grade 3
3.750600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.351800E-02
Grade 1-vs-Grade 3
1.755560E-01
Grade 1-vs-Grade 4
3.932800E-01
Grade 2-vs-Grade 3
4.325200E-01
Grade 2-vs-Grade 4
1.777750E-01
Grade 3-vs-Grade 4
3.750600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.571400E-01
Normal-vs-NonDiabetic
7.356200E-01
Diabetic-vs-NonDiabetic
1.383770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.932200E-01
Normal-vs-NoPancreatitis
6.183200E-01
Pancreatitis-vs-NoPancreatitis
4.517000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.467800E-01
Normal-vs-N1
3.832600E-01
N0-vs-N1
2.283000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.590200E-01
Normal-vs-TP53-NonMutant
9.611600E-01
TP53-Mutant-vs-TP53-NonMutant
2.992000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
